Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04941976Phase 4Completed
Phase 4, randomised, open-label trial of benzydamine in acute pharyngitis (2 arms), sponsored by Angelini Pharma. Primary endpoint: Percentage of responders at 2 minutes. Started Aug 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04941976.